NIH consensus development conference statement: Lactose intolerance and health.

Frederick J Suchy, Patsy M Brannon, Thomas O Carpenter, Jose R Fernandez, Vicente Gilsanz, Jeffrey B Gould, Karen Hall, Siu L Hui, Joanne Lupton, Julie Mennella, Natalie J Miller, Stavroula Kalis Osganian, Deborah E Sellmeyer, Marshall A Wolf
{"title":"NIH consensus development conference statement: Lactose intolerance and health.","authors":"Frederick J Suchy,&nbsp;Patsy M Brannon,&nbsp;Thomas O Carpenter,&nbsp;Jose R Fernandez,&nbsp;Vicente Gilsanz,&nbsp;Jeffrey B Gould,&nbsp;Karen Hall,&nbsp;Siu L Hui,&nbsp;Joanne Lupton,&nbsp;Julie Mennella,&nbsp;Natalie J Miller,&nbsp;Stavroula Kalis Osganian,&nbsp;Deborah E Sellmeyer,&nbsp;Marshall A Wolf","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health.</p><p><strong>Participants: </strong>A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience.</p><p><strong>Evidence: </strong>Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience.</p><p><strong>Conference process: </strong>The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.</p><p><strong>Conclusions: </strong>• Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.</p>","PeriodicalId":86986,"journal":{"name":"NIH consensus and state-of-the-science statements","volume":"27 2","pages":"1-27"},"PeriodicalIF":0.0000,"publicationDate":"2010-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NIH consensus and state-of-the-science statements","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health.

Participants: A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience.

Evidence: Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience.

Conference process: The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.

Conclusions: • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.

美国国立卫生研究院共识发展会议声明:乳糖不耐症与健康。
目的:为卫生保健提供者、患者和公众提供对乳糖不耐症和健康的现有数据的负责任的评估。参与者:一个非dhhs、非倡导者的14人小组,代表内科、儿科、儿科和成人内分泌学、胃肠病学、肝病学、新生儿和围产期学、老年病学、种族/民族差异、放射学、母婴营养学、维生素和矿物质代谢、营养科学、骨骼健康、预防医学、生物心理学、生物统计学、统计遗传学、流行病学和一名公众代表。此外,来自相关领域的22位专家向小组和会议听众介绍了数据。证据:专家介绍和明尼苏达大学循证实践中心通过医疗保健研究和质量机构编写的文献系统综述。科学证据优先于轶事经验。会议进程:小组根据公开论坛上提出的科学证据和已发表的科学文献起草了声明。声明草案在会议的最后一天提出,并分发给与会者征求意见。该委员会当天晚些时候在http://consensus.nih.gov上发布了一份修订后的声明。本声明是专家组的独立报告,不是NIH或联邦政府的政策声明。结论:•乳糖不耐症是一种真实且重要的临床综合征,但其真实患病率尚不清楚。•大多数患有乳糖吸收不良的人没有临床乳糖不耐症。许多认为自己有乳糖不耐症的人其实并不是乳糖吸收不良症患者。•许多患有乳糖不耐症或乳糖不耐症的人不吃乳制品,摄入的钙和维生素D不足,这可能使他们易患骨质疏松症,骨质疏松症和其他不良健康后果。在大多数情况下,个人不需要完全消除乳制品消费。•需要有或没有乳制品的循证饮食方法和补充策略,以确保乳糖不耐症患者适当摄入钙和其他营养素。•针对个人及其医疗保健提供者的教育计划和行为方法应得到开发和验证,以改善乳糖不耐症和乳制品避免患者的营养和症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信